Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Avg patent value: 4.34 M | |||
2 | Avg patent value: 3.79 M | |||
3 | Avg patent value: 3.28 M | |||
4 | Avg patent value: 220,000 | |||
5 |  STARTUP | Avg patent value: 0 |
Top 5 Key Players companies in Multiple sklerose
by Highest Patent Value in the Australia in 2022
The Multiple sklerose top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Multiple sklerose Key Players in the Australia. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
Page generation time:
Jul 23 2025